Get the Stockscreener App
31.17
1.95%
-0.62
Hinge Health Inc stock is traded at $31.17, with a volume of 1.33M.
It is down -1.95% in the last 24 hours and down -36.17% over the past month.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
See More
Previous Close:
$31.79
Open:
$32.41
24h Volume:
1.33M
Relative Volume:
0.91
Market Cap:
$2.45B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.69%
1M Performance:
-36.17%
6M Performance:
-48.52%
1Y Performance:
+0.00%
1-Day Range:
$30.88
$33.16
1-Week Range:
$30.88
$36.45
52-Week Range:
$30.88
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Name
Hinge Health Inc
Sector
Industry
Phone
415-689-8429
Address
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
31.17 | 2.50B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
183.65 | 30.22B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
54.91 | 9.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.68 | 6.92B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
79.45 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.73 | 6.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-14-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jun-16-25 | Initiated | Barclays | Overweight |
| Jun-16-25 | Initiated | BofA Securities | Buy |
| Jun-16-25 | Initiated | Canaccord Genuity | Buy |
| Jun-16-25 | Initiated | Evercore ISI | Outperform |
| Jun-16-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-25 | Initiated | Morgan Stanley | Overweight |
| Jun-16-25 | Initiated | Needham | Buy |
| Jun-16-25 | Initiated | Piper Sandler | Overweight |
| Jun-16-25 | Initiated | RBC Capital Mkts | Outperform |
| Jun-16-25 | Initiated | Raymond James | Outperform |
| Jun-16-25 | Initiated | Stifel | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-16-25 | Initiated | William Blair | Outperform |
View All
Hinge Health Inc Stock (HNGE) Latest News
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Jim Cramer Shed Light on These 19 Stocks Recently - Insider Monkey
Hinge Health (NYSE:HNGE) Sets New 1-Year LowHere's Why - MarketBeat
Jim Cramer Says Hinge Health Is “Going to Be One of the Better Stocks We’ve Seen in the Healthcare Sector” - Yahoo Finance
Physio App Maker Hinge Health, Backers Seek $437 Million IPO - MSN
Citizens reiterates Market Outperform rating on Hinge Health stock By Investing.com - Investing.com UK
Citizens reiterates Market Outperform rating on Hinge Health stock - Investing.com
Why Hinge Health Shares Are Sliding Despite Optimism - TipRanks
Hinge Health Inc. (NYSE:HNGE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Analyst Expectations For Hinge Health's Future - Benzinga
Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX) - The Globe and Mail
Freedom Capital Markets Initiates Coverage of Hinge Health (HNGE) with Buy Recommendation - Nasdaq
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings - Investing.com UK
Freedom Capital Markets initiates Buy on Hinge Health stock with $59 target - Investing.com
Canaccord Genuity reiterates Buy rating on Hinge Health stock ahead of earnings By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps - Investing.com Nigeria
Stifel reiterates Buy rating on Hinge Health stock citing MSK care gaps By Investing.com - Investing.com South Africa
Hinge Health Inc (HNGE) Trading Down 3.2% on Jan 20 - GuruFocus
Will Hinge Health Inc. (HNGE) beat estimates again in its next earnings report? - MSN
Assessing Hinge Health (HNGE) Valuation As Shares Show Recent Uptick But Weak Broader Momentum - Yahoo Finance
Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care - Chartmill
Hinge Health (NYSE:HNGE) Trading Down 7.8%Here's What Happened - MarketBeat
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
San Bernardino Sun - FinancialContent
Hinge Health: Strong Usage Momentum, Conservative Growth Expectations, and Competitive Moat Support Buy Rating - TipRanks
Hinge Health (NYSE:HNGE) Upgraded at Wells Fargo & Company - MarketBeat
Piper Sandler lowers Hinge Health stock price target to $60 from $71 - Investing.com Canada
Piper Sandler lowers Hinge Health stock price target to $60 from $71 By Investing.com - Investing.com South Africa
Hinge Health, Inc. Class A Common Stock (NY: HNGE - FinancialContent
HNGE Stock Coverage Initiated by Wells Fargo with Overweight Rat - GuruFocus
Hinge Health stock initiated with Overweight rating by Wells Fargo - Investing.com Australia
What earnings margins imply for Hinge Health Inc. Class stockPrice Action & Comprehensive Market Scan Insights - ulpravda.ru
Hinge Health announces $250M buyback program - MSN
Contact UsConcord Monitor - FinancialContent
Hinge Health (NYSE:HNGE) CEO Sells $7,729,922.70 in Stock - MarketBeat
Hinge Health (HNGE) CEO & 10% owner logs 166,665-share conversion, stock sales - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Needham names Hinge Health stock as top health tech pick for 2026 - Investing.com Nigeria
Needham names Hinge Health stock as top health tech pick for 2026 By Investing.com - Investing.com South Africa
Hinge Health (NYSE:HNGE) Earns Buy Rating from Needham & Company LLC - MarketBeat
Hinge Health Inc Stock (HNGE) Financials Data
There is no financial data for Hinge Health Inc (HNGE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
6.73%
16.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):